1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 8th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Medical Uses of Sodium Thiosulfate

Discussion in 'Other treatments' started by ScottTriGuy, Feb 18, 2020.

  1. ScottTriGuy

    ScottTriGuy Senior Member (Voting Rights)

    Messages:
    692
    I stumbled on sodium thiosulfate -- It is used historically for cyanide poisoning, but they are discovering other properties / uses -- the anti-inflammatory and neuroprotective effects piqued my interest:

    https://www.jneurology.com/articles/medical-uses-of-sodium-thiosulfate-neuromed-1-1032.php

    Abstract
    Sodium thiosulfate (STS) is an industrial chemical which also has a long medical history. It was originally used as an intravenous medication for metal poisoning. It has since been approved for the treatment of certain rare medical conditions. These include cyanide poisoning, calciphylaxis, and cisplatin toxicity. In vitro assays have demonstrated that it is an anti-inflammatory and neuroprotective agent. It therefore has potential for treating neurodegenerative diseases such as Alzheimer disease and Parkinson disease. NaSH has similar properties and is somewhat more powerful than STS in these in vitro assays. However STS has already been approved as an orally available treatment. STS may therefore be a readily available candidate for treating neurodegenerative disorders such as Alzheimer disease and Parkinson disease.



    https://link.springer.com/article/10.1186/s12974-016-0488-8

    Background
    Sodium thiosulfate (STS) is an industrial chemical which has also been approved for the treatment of certain rare medical conditions. These include cyanide poisoning and calciphylaxis in hemodialysis patients with end-stage kidney disease. Here, we investigated the anti-inflammatory activity of STS in our glial-mediated neuroinflammatory model.

    ....

    Conclusions
    Although NaSH was somewhat more powerful than STS in these in vitro assays, STS has already been approved as an orally available treatment. STS may therefore be a candidate for treating neurodegenerative disorders that have a prominent neuroinflammatory component.
     

Share This Page